Viewing nowCombinationCelebica Tablet 5/20 mg
Olmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Celtrion Pharmaceutical Co., Ltd.

MFDS item code 201505167 · Approved 2015.07.30 · Insurance code 693901790
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with essential hypertension who are not adequately controlled with monotherapy of amlodipine or olmesartan medoxomil. It helps effectively control blood pressure and reduces the risk of complications associated with hypertension. Regular use aids in improving cardiovascular health and maintaining stable blood pressure control. Therefore, it is very useful in the treatment of essential hypertension.
Take 1 tablet of this medicine once daily with water, with or without food. It is recommended, if possible, to take it at the same time each day (e.g., in the morning). It is recommended that the doses of the individual components (amlodipine or olmesartan medoxomil) be adjusted before starting this medicine; however, if blood pressure is not controlled with monotherapy with the individual components, switching directly to this medicine may be considered. The maximum dose of this medicine is 10/40 mg. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of 2 weeks or longer, taking the patient's blood pressure response into account. The recommended doses are as follows: - 5/20 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or olmesartan medoxomil 20 mg as monotherapy. - 10/20 mg: For patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 mg as monotherapy. - 5/40 mg: For patients whose blood pressure is not adequately controlled with 5/20 mg. - 10/40 mg: For patients whose blood pressure is not adequately controlled with 5/40 mg. ○ Patients with renal impairment: This medicine has not been studied in patients with renal impairment. However, in patients with mild or moderate renal impairment (creatine clearance 20-60mL/min), the maximum dose of olmesartan medoxomil is 20 mg once daily. Use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients receiving dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ○ Patients with reduced effective intravascular volume: In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. ○ Patients with hepatic impairment: Use with caution in patients with mild or moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 mg once daily, and the maximum dose is 20 mg once daily. In patients with hepatic impairment who are already receiving other antihypertensive medicines and/or diuretics, blood pressure and renal function should be closely monitored. Do not administer this medicine to patients with severe hepatic impairment. (See section 2, “Patients in whom this medicine must not be administered,” under Precautions for Use.) ○ Older adults: In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. In older adults, blood pressure should be monitored closely and more frequently.
○ Children: The safety and efficacy in pediatric patients under 18 years of age have not been established.
This medication can cause serious harm to the fetus and newborn if used during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals with allergies to the main ingredients or similar class drugs, nor in women who are pregnant or breastfeeding. This medication should also not be administered to patients with severe liver dysfunction, those undergoing kidney dialysis, or patients with certain heart valve diseases. In patients who have low body fluids or sodium levels, blood pressure may drop too low, so such patients should be closely monitored and treatment should be started gradually. There may be a sudden dilation of blood vessels leading to low blood pressure, thus caution is needed for patients with heart or vascular problems. Use with caution in patients with heart failure, and monitor renal function closely in patients with impaired kidney function while taking this medication. As this medication is metabolized in the liver, patients with poor liver function should be careful while taking it. During treatment, side effects such as dizziness, headache, fatigue, edema, or reduced blood pressure may occur; if severe abnormal symptoms arise, consult a physician. Pregnant women are advised to consult a doctor as this medication can have severe effects on the fetus; if planning to become pregnant or already pregnant, medical consultation is mandatory. Breastfeeding women should carefully consider the decision to take this medication as it can be passed to the baby through breast milk. Children under 18 years of age are not recommended to use this medication due to the lack of sufficient safety and efficacy data. Elderly individuals may have reduced liver, kidney, or heart function, so starting from a lower dose is recommended and careful monitoring is necessary. In cases of overdose, severe hypotension and heart dysfunction due to vascular dilation can occur, thus immediate medical treatment is required. This medication should be stored in a closed container protected from direct sunlight and moisture, and should not be transferred to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature to preserve the drug's efficacy and safety.
White round film-coated tablets
28 tablets/Alu-Alu
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Celtrion Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.